The placebo effect is real, measurable, and rooted in specific brain circuits and biochemical processes. It’s not “all in your head” in the dismissive sense. Your brain physically releases its own painkillers, alters how it processes symptoms, and produces changes that show up on brain scans and in lab results. Far from being a sign of gullibility, the placebo response is a built-in feature of human biology that researchers have spent decades mapping in detail.
What Happens in Your Brain
When you expect relief from a treatment, your brain can release its own opioids, the same class of chemicals that make prescription painkillers work. This isn’t speculation. In a landmark study published in The Lancet, researchers gave dental surgery patients either a placebo or an opioid-blocking drug. Patients who had responded to the placebo experienced significantly more pain when the blocker was introduced, confirming that their relief had come from real opioid activity in the brain. The blocker had no effect on patients who hadn’t responded to the placebo in the first place, meaning the entire pain difference between the two groups was explained by the brain’s own chemical release.
Neuroscientists have since traced the specific circuit involved. In research published in the Proceedings of the National Academy of Sciences, a team found that neurons in the anterior cingulate cortex (a region involved in processing expectations and emotions) communicate with a structure in the middle of the brain called the pontine nucleus, which turned out to contain a high concentration of genes related to opioid production. From there, signals travel to the cerebellum. When researchers blocked opioid receptors in the animals, the placebo response disappeared.
Two Ways Your Body Learns to Respond
The placebo effect isn’t one single phenomenon. Researchers have identified at least two distinct mechanisms that drive it, and they can operate independently.
The first is expectation. If you believe a pill will help, your brain begins generating the response it anticipates. This is called response expectancy, a theory formalized in the late 1980s. It explains why the same sugar pill can reduce pain when handed over by a confident doctor in a white coat but do nothing when found in an unmarked bag.
The second mechanism is classical conditioning, the same process that made Pavlov’s dogs salivate at a bell. If you’ve taken a real painkiller many times and it always came in a blue capsule, your body can eventually produce a partial pain-relief response to a blue capsule alone. Research published in Frontiers in Psychiatry has shown that this conditioned response can occur automatically, without any conscious expectation of relief. In other words, your body can “learn” to respond to a placebo even when your mind isn’t involved in generating the effect.
It Works Even When You Know It’s a Placebo
One of the most surprising findings in placebo research is that deception isn’t required. In open-label placebo studies, participants are told explicitly that they’re receiving an inert pill with no active ingredients, and many still improve.
Harvard Medical School researchers found that patients with opioid use disorder who knowingly received placebo pills alongside their standard treatment were significantly more likely to stay in treatment and reported better sleep quality than those on standard treatment alone. Similar open-label results have appeared across a range of conditions: cancer survivors experienced less fatigue, people with irritable bowel syndrome saw symptom relief, and patients with chronic low back pain reported improvement, all while fully aware they were taking sugar pills.
Conditioning helps explain why this works. When participants are first paired with an active medication and then switched to a placebo, their bodies continue producing a partial response. This approach has shown measurable benefits for insomnia, ADHD symptoms, and post-surgical pain.
How Large the Effect Can Be
The size of the placebo response varies by condition, but in some areas it’s substantial enough to complicate drug development.
In irritable bowel syndrome trials, a meta-analysis in The Lancet Gastroenterology and Hepatology found that 27% of patients in placebo groups reported global improvement, and 34% reported meaningful reductions in abdominal pain. These numbers are high enough that new IBS drugs must clear a significant bar just to prove they outperform placebo.
In depression research, the placebo response is even more pronounced. A JAMA Network Open analysis of 50 randomized trials in treatment-resistant depression found a large and consistent placebo effect across different treatment types. This is one reason why antidepressant trials frequently fail to show a statistically significant advantage over placebo: not because the drugs don’t work, but because the placebo arm improves so much. It’s worth noting, though, that some of the improvement seen in placebo groups reflects factors beyond the placebo effect itself, including the natural tendency for severe symptoms to ease over time and the benefit of regular contact with clinicians during a trial.
The Nocebo Effect: When Expectations Backfire
The same biological machinery that produces placebo benefits can work in reverse. The nocebo effect occurs when negative expectations produce real, measurable symptoms. If you’re told a medication causes nausea, you’re more likely to feel nauseated, even if you received an inert pill.
This shows up in everyday life more than most people realize. Drinking decaf coffee late at night can keep you awake if you believe it’s caffeinated. Research suggests that some of the muscle pain people report while taking cholesterol-lowering statins may be driven partly by the nocebo effect, since patients who don’t know they’re on the drug report less pain. A study on COVID-19 vaccines found that some post-vaccination fatigue and pain may have been amplified by hearing others describe those same side effects.
Pediatric concussion research has raised a particularly striking concern: the way a healthcare provider describes expected pain and recovery time after a child’s head injury may itself influence how much pain the child experiences and how long recovery takes.
Using Placebos in Medical Practice
Given how robust the placebo effect is, a natural question is whether doctors should prescribe placebos. The American Medical Association permits it under specific conditions. Physicians can use placebos in clinical care, but only with the patient’s cooperation. The AMA’s guidelines require doctors to explain that evaluating different interventions, including a placebo, may help better understand the patient’s condition, and to obtain the patient’s general consent. The doctor doesn’t need to announce the exact moment a placebo is given, but the patient must know it’s part of the plan.
What’s explicitly prohibited is using a placebo just to manage a difficult patient. The AMA considers this putting the physician’s convenience above the patient’s welfare. The ethical framework reflects the same lesson that open-label research has taught: transparency doesn’t destroy the placebo effect, and trust between patient and provider may actually enhance it.